Breast lumps secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Breast lumps}} | {{Breast lumps}} | ||
{{CMG}} {{AE}} {{S.M} | {{CMG}} {{AE}} {{S.M}} | ||
Secondary prevention of breast lumps is the same as primary prevention <ref name="pmid29284222">{{cite journal| author=Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B et al.| title=Primary and secondary prevention of breast cancer. | journal=Ann Agric Environ Med | year= 2017 | volume= 24 | issue= 4 | pages= 549-553 | pmid=29284222 | doi=10.26444/aaem/75943 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29284222 }} </ref>. | Secondary prevention of breast lumps is the same as primary prevention <ref name="pmid29284222">{{cite journal| author=Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B et al.| title=Primary and secondary prevention of breast cancer. | journal=Ann Agric Environ Med | year= 2017 | volume= 24 | issue= 4 | pages= 549-553 | pmid=29284222 | doi=10.26444/aaem/75943 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29284222 }} </ref>. | ||
Revision as of 17:47, 19 December 2018
|
Breast lumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast lumps secondary prevention On the Web |
|
American Roentgen Ray Society Images of Breast lumps secondary prevention |
|
Risk calculators and risk factors for Breast lumps secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Secondary prevention of breast lumps is the same as primary prevention [1].
- Surveillance and follow-up to reduce breast cancer reoccurance[2]
- History and clinical physical examination required every 4 to 6 months for 5 years
- Annual mammography and clinical physical examination after first 5 years
- Annual gynecological assessment for uterus evaluation for women on tamoxifen
- Bone health assessment for women on aromatase inhibitor and those who had ovarian failure secondary to treatment
- Establishment of physical activity, alcohol intake, weight gain
References
- ↑ Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B; et al. (2017). "Primary and secondary prevention of breast cancer". Ann Agric Environ Med. 24 (4): 549–553. doi:10.26444/aaem/75943. PMID 29284222.
- ↑ de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ (2004). "Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review". J Clin Oncol. 22 (19): 4010–8. doi:10.1200/JCO.2004.06.080. PMID 15459225.